F138
尿酸ＳＯＳ（エスオーエス）
井藤漢方製薬株式会社販売休止中
加工食品(錠剤、カプセル剤等)
Category
Notif. Date
2020-06-06
Planned Sale Date
Functional Claim
本品には、ルテオリンが含まれます。ルテオリンには尿酸値が高め（5.5mg/dL以上7.0mg/dL未満）な男性の尿酸値を下げる機能が報告されています。
Functional Ingredient
Content
Functional Claim
本品には、ルテオリンが含まれます。ルテオリンには尿酸値が高め（5.5mg/dL以上7.0mg/dL未満）な男性の尿酸値を下げる機能が報告されています。
AI Summary
Automatically generated from notification documents
This product contains luteolin, which has been reported to reduce uric acid levels in men with moderately high levels (5.5mg/dL to under 7.0mg/dL).
Key Features
[
"
F
o
r
e
l
e
v
a
t
e
d
u
r
i
c
a
c
i
d
"
,
"
F
u
n
c
t
i
o
n
a
l
i
n
g
r
e
d
i
e
n
t
l
u
t
e
o
l
i
n
"
,
"
R
e
p
o
r
t
e
d
u
r
i
c
a
c
i
d
r
e
d
u
c
t
i
o
n
"
,
"
D
a
i
l
y
h
e
a
l
t
h
s
u
p
p
o
r
t
"
]
Men with moderately high uric acid levels.
Notification Documents
| Product Name | 尿酸ＳＯＳ（エスオーエス） |
| Category | |
| Food Classification | 加工食品(錠剤、カプセル剤等) |
| Functional Ingredient Name | ルテオリン |
| Functional ingredient is an extract | No |
| Functional Claim | 本品には、ルテオリンが含まれます。ルテオリンには尿酸値が高め（5.5mg/dL以上7.0mg/dL未満）な男性の尿酸値を下げる機能が報告されています。 |
| Consumer Affairs Department Contact | |
| Information Disclosure Website URL |
| (1) Precautions for Intake | |
| (2) Safety Evaluation Method | |
| (3) Notifier's Safety Evaluation |
| Details |
| (1) Functionality Evaluation Method | |
| (2) Notifier's Functionality Evaluation |
| Reason for not classifying as tablet/capsule food | |
| Primary Target Audience | |
| Planned Sales Start Date | |
| Change History (before Mar 31, 2025) | |
| Change History (from Apr 1, 2025) | |
| Before/After Comparison Table | |
| Before/After Comparison Table (attachments) | |
| If re-notification | No |
| Existing Notification Number | |
| Reason for Maintaining Identity | |
| Post-notification Sales Status | 販売休止中 |
| Reason for Notification Withdrawal |
| Month of Last Self-Inspection Report |